| abstract |
Described herein are solid forms and complexes of chemical compounds that modulate kinase activity, including PI3 kinase activity, pharmaceutical compositions, and methods of treating diseases and disorders associated with kinase activity, including PI3 kinase activity. Also provided herein are methods of preparing the compounds, polymorphic forms, co-crystals and amorphous forms thereof, and pharmaceutical compositions thereof. |